Immunovant, Inc. IMVT Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total loss before income taxes by Geography | ||||||
| Bermuda | -$39K+61.0% | -$54.25K+41.5% | -$69.5K+18.7% | -$84.75K-8.3% | -$100K-40.8% | |
| Switzerland | -$606.29M-53.4% | -$553.5M-55.1% | -$500.7M-57.0% | -$447.91M-59.6% | -$395.12M-62.9% | |
| United Kingdom | -$55K— | -$41.25K— | -$27.5K— | -$13.75K— | $0— | |
| United States | $100.99M+670% | $71.31M+511% | $41.63M+346% | $11.95M+172% | -$17.73M-9.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Immunovant, Inc. break its business down?
- Immunovant, Inc. (IMVT) reports total loss before income taxes by geography across 4 parts — Bermuda, Switzerland, United Kingdom and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Immunovant, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Immunovant, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.